Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Opening Ceremony of CStone Pharmaceuticals' Suzhou Translational Medicine Research Center and an associated Immuno-Oncology Forum was Successfully Held in Suzhou 2017-11-03 14:16
WuXi Biologics and Pall Corporation Establish Joint Continuous Bioprocess Laboratory 2017-11-03 10:30
iPharma Enters Into Licensing Agreement With Boehringer Ingelheim to Obtain Worldwide Rights to FAK Inhibitor Oncology Development Program 2017-11-02 23:03
China Biologic Reports Unaudited Financial Results for the Third Quarter of 2017 2017-11-02 04:30
ImmunoMet Appoints Benjamin R. Cowen, PhD, MBA, as Chief Executive Officer 2017-11-01 20:30
TWi Biotechnology Inc. Presents Positive Results from AC-201 CR Phase 2 Proof-of-Concept Study in Gout Patients in 2017 ACR/ARPH Annual Meeting 2017-11-01 17:05
IFPBM to Attend HAA 2017 Scientific Meeting on 29th October to 1st November in Sydney Australia 2017-10-25 21:31
China Biologic Products to Report Third Quarter of 2017 Financial Results 2017-10-25 20:00
Lianluo Smart Presents at the Summit Forum of Sleep Respiratory Diseases in Shandong Province 2017-10-24 21:00
CStone Pharmaceuticals Announces Dosing the First Patient of CS1001: China's First Fully Human, Full-length Anti-PD-L1 Monoclonal Antibody 2017-10-20 20:50
WuXi AppTec Acquires ResearchPoint Global to Better Enable Clinical Development Worldwide 2017-10-18 05:30
Lianluo Smart Announces Presentation in Major International Cardiology Events 2017-10-16 21:00
China Biologic Products Announces Conference Call to Discuss TianXinFu Acquisition 2017-10-13 20:00
China Biologic Agrees to Acquire TianXinFu from PWM 2017-10-12 20:30
Samsung BioLogics Receives the 1st FDA Approval at the World's Largest Plant 2017-10-12 11:00
A Fashion Week First: Traditional Chinese Medicine Brand GuangYuYuan on the Runway 2017-10-10 22:10
China Biologic Receives Approval for Commercial Manufacturing of Human Fibrinogen 2017-10-09 20:30
WuXi AppTec Receives 2017 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan 2017-10-09 08:00
ImmunoMet Announces Initiation of Phase 1 Clinical Study of IM156, an OXPHOS Inhibitor, in Patients with Solid Tumors 2017-10-03 20:30
DNA Nanoswitch To Control Enzyme Activity 2017-09-28 21:00
1 235 236 237 238 239 421